Pharmaceutical Accountability Foundation

PAF Intro Healthcare is a human right. Abusive pricing should not limit access to it. We work to make sure it doesn't. Who we are arrow_forward_ios What we do arrow_forward_ios Support us arrow_forward_ios Humira case Pharma companies have a duty of care to protect patients' right to health. We use the law to hold them accountable. Legal guidelines for health arrow_forward_ios Our latest case: Humira arrow_forward_ios

Recent News

2022 Year in Review: Highlights from the Pharmaceutical Accountability Foundation

Farma ter Verantwoording (The Pharmaceutical Accountability Foundation, PAF) had a busy 2022, with several important steps forward in its mission to further affordable access to...

What is still needed to ensure the realisation of the human right to health?

The practical meaning of the human right to the highest attainable standard of health has evolved since its first articulation in the Constitution of the...

PAF welcomes the news that the Spanish competition authority has fined Leadiant €10,25 million

AMSTERDAM: The Pharmaceutical Accountability Foundation (PAF), a group of legal and medical experts and public health advocates, today welcomes the news that the Spanish competition...

Martina Liccardo’s take on the role of the European Medicine Agency in Leadiant’s price misuse with CDCA

As an international student I have always sought out opportunities to meet local people and to broaden my personal and professional network. When provided with the...

Pharma companies mostly fail to meet human rights principles, but a few show promise

The new Fair Pharma Scorecard – developed by the Pharmaceutical Accountability Foundation – shows that 19 out of 26 pharmaceutical companies scored poorly on their...

How Fair is Pharma?

The Pharmaceutical Accountability Foundation invites you to join our event presenting the Fair Pharma Scorecard, on Thursday 30 June 4PM CET.  Please register here. Fair Pharma Scorecard To...

Recent Tweets

Misuse & overuse of antimicrobials are key drivers of #AntimicrobialResistance. A new report from HAI & @PHGFoundation says development and widespread use of more accurate and rapid diagnostic testing can play a major role in tackling #AMR. Find out more: https://haiweb.org/publication/diagnostics-to-address-antimicrobial-resistance/

Check out our highlights from 2022 in our yearly review! https://www.pharmaceuticalaccountability.org/2023/01/16/2022-year-in-review-highlights-from-the-pharmaceutical-accountability-foundation/ #MakePharmaFair

What is needed to ensure the realisation of the human right to health? Our infographic outlines the current state of play in pharmaceutical human rights responsibilities, and suggests how to further strengthen pharmaceutical accountability. Read the blog: https://www.pharmaceuticalaccountability.org/2023/01/10/what-is-still-needed-to-ensure-the-realisation-of-the-human-right-to-health/

Load More